Hodgson Lydia相关文献与解析，生知库 | 链接生命科学的每一步

日期影响因子

Survival Determinants and Treatment Outcomes of Patients with Small Cell Lung Cancer and Brain Metastases: A U.S. National Analysis

小细胞肺癌脑转移患者的生存决定因素和治疗结果：一项美国全国性分析

影响因子:4.4

doi:10.3390/cancers17233833

Qidwai, Khalid Ahmad; Sarfraz, Zouina; Mustafayev, Khalis; Hodgson, Lydia C; Maharaj, Arun; Sen, Triparna; Ranjan, Tulika; Ahluwalia, Manmeet S

细胞生物学

发表日期：2025

文献求助收藏

Survival in Patients with Colorectal Cancer and Isolated Brain Metastases: Temporal Trends and Prognostic Factors from the National Cancer Database (2010-2020)

结直肠癌合并孤立性脑转移患者的生存情况：来自国家癌症数据库（2010-2020 年）的时间趋势和预后因素

影响因子:4.4

doi:10.3390/cancers17152531

Sarfraz, Zouina; Jayram, Diya; Ozair, Ahmad; Hodgson, Lydia; Bellur, Shreyas; Maharaj, Arun; Venur, Vyshak A; Mukherjee, Sarbajit; Ahluwalia, Manmeet S

发表日期：2025

文献求助收藏

Tucatinib, trastuzumab, and capecitabine with stereotactic radiosurgery in patients with brain metastases from HER-2 positive breast cancer (TUTOR): Study protocol for a multicenter phase 1 clinical trial

Tucatinib、曲妥珠单抗和卡培他滨联合立体定向放射外科治疗HER-2阳性乳腺癌脑转移患者（TUTOR）：一项多中心I期临床试验的研究方案

期刊:BMC Cancer

影响因子:3.4

doi:10.1186/s12885-025-15224-3

Sarfraz, Zouina; Ozair, Ahmad; Bardhan, Mainak; Starosciak, Amy K; Perche, Dilanis C; Hodgson, Lydia C; Odia, Yazmin; Mehta, Minesh P; Kotecha, Rupesh; McDermott, Michael W; Maharaj, Arun; Leon, Ana Cristina Sandoval; Mahtani, Reshma; Ahluwalia, Manmeet S

发表日期：2025

文献求助收藏

Association of Health Disparities with Glioblastoma Treatment and Outcomes: Insights from a 15-Year National Cohort (2005-2020)

健康差异与胶质母细胞瘤治疗和结果的关联：来自一项为期 15 年的全国队列研究（2005-2020 年）的启示

期刊:Brain Sciences

影响因子:2.8

doi:10.3390/brainsci15060556

Sarfraz, Zouina; Jayram, Diya; Ozair, Ahmad; Hodgson, Lydia; Bellur, Shreyas; Maharaj, Arun; Mansouri, Alireza; Ahluwalia, Manmeet S

细胞生物学

发表日期：2025

文献求助收藏

Phase 1 Study of Accelerated Hypofractionated Radiation Therapy With Concurrent Chemotherapy for Stage III Non-Small Cell Lung Cancer: CALGB 31102 (Alliance)

III期非小细胞肺癌加速低分割放射治疗联合同步化疗的I期研究：CALGB 31102（联盟）

期刊:International Journal of Radiation Oncology Biology Physics

影响因子:6.5

doi:10.1016/j.ijrobp.2018.01.046

Urbanic, James J; Wang, Xiaofei; Bogart, Jeffrey A; Stinchcombe, Thomas E; Hodgson, Lydia; Schild, Steven E; Bazhenova, Lyudmila; Hahn, Olwen; Salgia, Ravi; Vokes, Everett E

细胞生物学

发表日期：2018

文献求助收藏

Phase III Randomized, Placebo-Controlled, Double-Blind Trial of Celecoxib in Addition to Standard Chemotherapy for Advanced Non-Small-Cell Lung Cancer With Cyclooxygenase-2 Overexpression: CALGB 30801 (Alliance)

一项 III 期随机、安慰剂对照、双盲试验，评估塞来昔布联合标准化疗治疗环氧合酶-2 过表达的晚期非小细胞肺癌的疗效：CALGB 30801（Alliance）

期刊:Journal of Clinical Oncology

影响因子:41.9

doi:10.1200/JCO.2016.71.3743

Edelman, Martin J; Wang, Xiaofei; Hodgson, Lydia; Cheney, Richard T; Baggstrom, Maria Q; Thomas, Sachdev P; Gajra, Ajeet; Bertino, Erin; Reckamp, Karen L; Molina, Julian; Schiller, Joan H; Mitchell-Richards, Kisha; Friedman, Paula N; Ritter, Jon; Milne, Ginger; Hahn, Olwen M; Stinchcombe, Thomas E; Vokes, Everett E

细胞生物学

发表日期：2017

文献求助收藏

Validation of Progression-Free Survival as a Surrogate Endpoint for Overall Survival in Malignant Mesothelioma: Analysis of Cancer and Leukemia Group B and North Central Cancer Treatment Group (Alliance) Trials

恶性间皮瘤中无进展生存期作为总生存期替代终点的验证：癌症和白血病B组及北中部癌症治疗组（联盟）试验分析

期刊:Oncologist

影响因子:4.2

doi:10.1634/theoncologist.2016-0121

Wang, Xiaofei; Wang, Xiaoyi; Hodgson, Lydia; George, Stephen L; Sargent, Daniel J; Foster, Nate R; Ganti, Apar Kishor; Stinchcombe, Thomas E; Crawford, Jeffrey; Kratzke, Robert; Adjei, Alex A; Kindler, Hedy L; Vokes, Everett E; Pang, Herbert

发表日期：2017

文献求助收藏

A phase II study of induction chemotherapy followed by thoracic radiotherapy and erlotinib in poor-risk stage III non-small-cell lung cancer: results of CALGB 30605 (Alliance)/RTOG 0972 (NRG)

一项 II 期研究，评估诱导化疗后胸部放疗和厄洛替尼治疗预后不良的 III 期非小细胞肺癌的疗效：CALGB 30605 (Alliance)/RTOG 0972 (NRG) 研究结果

期刊:Journal of Thoracic Oncology

影响因子:20.8

doi:10.1097/JTO.0000000000000347

Lilenbaum, Rogerio; Samuels, Michael; Wang, Xiaofei; Kong, Feng Ming; Jänne, Pasi A; Masters, Gregory; Katragadda, Sreedhar; Hodgson, Lydia; Bogart, Jeffrey; Bradley, Jeffrey; Vokes, Everett

细胞生物学

发表日期：2015

文献求助收藏

CALGB 30704 (Alliance): A randomized phase II study to assess the efficacy of pemetrexed or sunitinib or pemetrexed plus sunitinib in the second-line treatment of advanced non-small-cell lung cancer

CALGB 30704（联盟）：一项随机 II 期研究，旨在评估培美曲塞、舒尼替尼或培美曲塞联合舒尼替尼在晚期非小细胞肺癌二线治疗中的疗效。

期刊:Journal of Thoracic Oncology

影响因子:20.8

doi:10.1097/JTO.0000000000000071

Heist, Rebecca S; Wang, Xiaofei; Hodgson, Lydia; Otterson, Gregory A; Stinchcombe, Thomas E; Gandhi, Leena; Villalona-Calero, Miguel A; Watson, Peter; Vokes, Everett E; Socinski, Mark A

细胞生物学

发表日期：2014

文献求助收藏

Phase II study of induction cisplatin and irinotecan followed by concurrent carboplatin, etoposide, and thoracic radiotherapy for limited-stage small-cell lung cancer, CALGB 30206

CALGB 30206 是一项针对局限期小细胞肺癌的 II 期研究，评估了顺铂和伊立替康诱导化疗后序贯卡铂、依托泊苷和胸部放疗的疗效。

期刊:Journal of Thoracic Oncology

影响因子:20.8

doi:10.1097/JTO.0b013e31827628e1

Kelley, Michael J; Bogart, Jeffrey A; Hodgson, Lydia D; Ansari, Rafat H; Atkins, James N; Pang, Herbert; Green, Mark R; Vokes, Everett E

细胞生物学

发表日期：2013

文献求助收藏